Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

MLA

You, Seng Chan, et al. “Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.” JAMA, vol. 324, no. 16, Oct. 2020, pp. 1640–50. EBSCOhost, https://doi.org/10.1001/jama.2020.16167.

APA

You, S. C., Rho, Y., Bikdeli, B., Kim, J., Siapos, A., Weaver, J., Londhe, A., Cho, J., Park, J., Schuemie, M., Suchard, M. A., Madigan, D., Hripcsak, G., Gupta, A., Reich, C. G., Ryan, P. B., Park, R. W., & Krumholz, H. M. (2020). Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA, 324(16), 1640–1650. https://doi.org/10.1001/jama.2020.16167

Chicago

You, Seng Chan, Yeunsook Rho, Behnood Bikdeli, Jiwoo Kim, Anastasios Siapos, James Weaver, Ajit Londhe, et al. 2020. “Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.” JAMA 324 (16): 1640–50. doi:10.1001/jama.2020.16167.